z-logo
open-access-imgOpen Access
Neuroactive Antiretroviral Drugs Do Not Influence Neurocognitive Performance in Less Advanced HIV-Infected Patients Responding to Highly Active Antiretroviral Therapy
Author(s) -
Maria Letizia Giancola,
Patrizia Lorenzini,
Pietro Balestra,
Dora Larussa,
Francesco Baldini,
Angela Corpolongo,
Pasquale Narciso,
Rita Bellagamba,
Valerio Tozzi,
Andrea Antinori
Publication year - 2006
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/01.qai.0000197077.64021.07
Subject(s) - neurocognitive , medicine , odds ratio , regimen , confidence interval , reverse transcriptase inhibitor , antiretroviral therapy , antiretroviral drug , cerebrospinal fluid , human immunodeficiency virus (hiv) , viral load , immunology , gastroenterology , cognition , psychiatry
To analyze the effect of antiretroviral therapy, including drugs that have good penetration in cerebrospinal fluid (CSF), on neuropsychologic performance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here